Lymphopenic Community Acquired Pneumonia (L-Cap), an Immunological Phenotype Associated With Higher Risk of Mortality

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2017.09.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Severe Community-Acquired Pneumonia: Risk Factors for In-Hospital Mortality

Critical Care
Critical CareIntensive Care Medicine
2012English

An Evaluation of Prescribing Practices for Community-Acquired Pneumonia (CAP) in Mongolia

BMC Health Services Research
Health Policy
2013English

One-Year Mortality in Patients With Community-Acquired Pneumonia

Journal of Respiratory Infections
2017English

The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)

Journal of Managed Care Pharmacy
2009English

Immunological Reactivity Among Young Patients With Community-Acquired Pneumonia and Cytomegaloviral Persistence

Zaporozhye Medical Journal
2018English

The Risk Stratification in Community-Acquired Pneumonia

American Journal of Emergency Medicine
MedicineEmergency Medicine
2019English

Immunological Aspects of Cytomegalovirus Infection in Community-Acquired Pneumonia Among Young Adults.

Medicni perspektivi (Medical perspectives)
2018English

Community-Acquired Pneumonia

2010English

Community Acquired Pneumonia

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy